Phase II Radiation Treatment Modality
Organization | Field Name | ID | Required |
---|---|---|---|
KCR | Phase II Radiation Treatment Modality (RadP2TxMod) | 50437 | yes |
NAACCR | Phase II Radiation Treatment Modality | yes |
Field length: 2
Radiation Treatment Modality--Phase I, II, and III, effective 01/01/2018, identify the radiation modality administered during the first, second, and third phase, respectively, of radiation treatment delivered during the first course of treatment.
Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities.
Code | Description |
---|---|
00 | No radiation treatment |
01 | External beam, NOS |
02 | External beam, photons |
03 | External beam, protons |
04 | External beam, electrons |
05 | External beam, neutrons |
06 | External beam, carbon ions |
07 | Brachytherapy, NOS |
08 | Brachytherapy, intracavitary, LDR |
09 | Brachytherapy, intracavitary, HDR |
10 | Brachytherapy, Interstitial, LDR |
11 | Brachytherapy, Interstitial, HDR |
12 | Brachytherapy, electronic |
13 | Radioisotopes, NOS |
14 | Radioisotopes, Radium-232 |
15 | Radioisotopes, Strontium-89 |
16 | Radioisotopes, Strontium-90 |
98 | Radiation therapy administered, but treatment modality is not specified or unknown |
99 | TUnknown if radiation treatment administered |
Refer to the current STandards for Oncology Registry Entry (STORE) Manual and the CTR Guide to Coding Radiation Therapy Treatment in the STORE (see 2024 STORE Manual, Appendix M)
Coding Instructions
1. Assign code 13 Radioisotopes, NOS for Radioembolization procedures, e.g., intravascular yttrium-90 or lutetium-177